Description
The purpose of this notice is to advise stakeholders that Health Canada is proposing to: maintain the flexibilities and regulatory oversight provided by the Interim order respecting clinical trials for medical devices and drugs relating to COVID-19 until at least the fall of 2021, and bring forward regulatory amendments that would allow the flexibilities under the Interim Order to continue after the fall of 2021.
Resources
| Name | Format | Description | Link |
|---|---|---|---|
| Ensuring predictability for COVID-19 clinical trials and proposal for clinical trials records retention: Notice to stakeholders | HTML | Open resource | |
| Ensuring predictability for COVID-19 clinical trials and proposal for clinical trials records retention: Notice to stakeholders | HTML | Open resource |